Annual Report 2021

Consolidated Statement of Changes in Net Equity

For details see Note (34) “Equity”.

€ million

 

Equity capital

 

Capital reserves

 

Retained earnings

 

Gains/losses recognized in equity

 

Equity attributable to
share­holders
of Merck KGaA,
Darmstadt,
Germany

 

Non-controlling interests

 

Total equity

Jan. 1, 2020

 

565

 

3,814

 

11,483

 

1,980

 

17,841

 

73

 

17,914

Profit after tax

 

 

 

1,987

 

 

1,987

 

7

 

1,994

Gains/losses recognized in equity

 

 

 

-357

 

-1,790

 

-2,147

 

-2

 

-2,149

Comprehensive income

 

 

 

1,631

 

-1,790

 

-160

 

5

 

-155

Dividend payments

 

 

 

-168

 

 

-168

 

-7

 

-175

Profit transfer to/from E. Merck KG, Darmstadt, Germany, including changes in reserves

 

 

 

-567

 

 

-567

 

 

-567

Transactions with no change of control

 

 

 

-1

 

 

-1

 

 

-1

Change in scope of consolidation/Other

 

 

 

 

 

 

 

Dec. 31, 2020

 

565

 

3,814

 

12,378

 

189

 

16,946

 

71

 

17,017

€ million

 

Equity capital

 

Capital reserves

 

Retained earnings

 

Gains/losses recognized in equity

 

Equity attributable to
share­holders
of Merck KGaA,
Darmstadt,
Germany

 

Non-controlling interests

 

Total equity

Jan. 1, 2021

 

565

 

3,814

 

12,378

 

189

 

16,946

 

71

 

17,017

Profit after tax

 

 

 

3,055

 

 

3,055

 

10

 

3,065

Gains/losses recognized in equity

 

 

 

599

 

1,635

 

2,234

 

5

 

2,239

Comprehensive income

 

 

 

3,653

 

1,635

 

5,289

 

15

 

5,304

Dividend payments

 

 

 

-181

 

 

-181

 

-8

 

-189

Profit transfer to/from E. Merck KG, Darmstadt, Germany, including changes in reserves

 

 

 

-716

 

 

-716

 

 

-716

Transactions with no change of control

 

 

 

 

 

 

 

Change in scope of consolidation/Other

 

 

 

 

 

 

 

Dec. 31, 2021

 

565

 

3,814

 

15,134

 

1,824

 

21,338

 

78

 

21,416

Share this page: